Latest Close
$13.13
News
ADPT
Adaptive Biotechnologies Corpor News
This news view pulls recent coverage and headlines tied to ADPT.
1y Change
$4.09 (+45.24%)
Market Cap
$2.1B
Sector
Healthcare
Industry
Diagnostics & Research
Recommendation
strong_buy
Morgan Stanley Lowers Price Target on Adaptive Biotechnologies to $18 From $21, Keeps Equalweight Rating
MT Newswires • May 12, 2026
Read articleAssessing Adaptive Biotechnologies (ADPT) Valuation After Strong MRD Growth And Raised Full Year Guidance
Simply Wall St. • May 11, 2026
Read articleAdaptive Biotechnologies Q2 Loss Narrows, Revenue Rises
MT Newswires • May 6, 2026
Read articleAdaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks • May 5, 2026
Read articleAdaptive Biotechnologies Q1 Earnings Call Highlights
MarketBeat • May 5, 2026
Read articleAdaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates
Zacks • May 5, 2026
Read article